Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 27: 1256-1261, 1981;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKnight, R. P.
Right arrow Articles by Willis, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKnight, R. P.
Right arrow Articles by Willis, J. E.

Clinical Chemistry, Vol 27, 1256-1261, Copyright © 1981 by American Association for Clinical Chemistry

Evaluation of a method for enzymic radiochemical assay of tobramycin and amikacin in serum

RP McKnight and JE Willis

This enzymic radiochemical procedure for measuring tobramycin and amikacin in serum is based on the transfer of the 14C-acetyl group from [14C]acetyl-coenzyme A to the 6' nitrogen atom of the drug by the enzyme kanamycin 6'-acetyltransferase (EC 2.3.1.55). The transfer, stoichiometric and quantitative, is complete after 10-min incubation at 37 degrees C. The labeled acetylaminoglycoside is adsorbed onto phosphocellulose paper discs, which are washed to removed any unreacted [14C]acetyl-coenzyme A. The radioactivity is then eluted into liquid scintillation counting vials and counted for 1 min each. The assay detects as little as 2 ng of either drug and the standard curve is linear into the toxic range of concentrations. Most of the commonly administered aminoglycosides act as substrates in the assay, except for the C1 component of gentamicin C complex. Neither hemolysis, lipemia, nor icterus interfere with the assay. Results compare favorably with those determined by radioimmunoassay and a microbiological method.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American Association for Clinical Chemistry.